Alefacept for the treatment of psoriasis

HAYES, Inc.
Record ID 32004000351
English
Authors' objectives:

Alefacept is a biologic therapy for chronic plaque psoriasis (CPP). Alefacept reduces the symptoms of CPP by inhibiting the activation of T lymphocytes and by reducing the memory effector T-lymphocyte subtype populations that play a role in the pathophysiology of CPP.

Authors' methods: Review
Details
Project Status: Completed
URL for project: http://www.hayesinc.com/
Year Published: 2003
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Alefacept
  • Therapeutics
  • Psoriasis
Contact
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.